Nucleus Software (India) Performance
NUCLEUS Stock | 804.75 1.50 0.19% |
The company secures a Beta (Market Risk) of 0.0955, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Nucleus Software's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nucleus Software is expected to be smaller as well. At this point, Nucleus Software Exports has a negative expected return of -0.34%. Please make sure to verify Nucleus Software's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Nucleus Software Exports performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Nucleus Software Exports has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Forward Dividend Yield 0.0155 | Payout Ratio 0.2217 | Last Split Factor 2:1 | Forward Dividend Rate 12.5 | Ex Dividend Date 2024-07-08 |
1 | Federal Bank Implements Nucleus Softwares Transaction Banking Platform FinnAxia - Marketscreener.com | 01/02/2025 |
2 | The total return for Nucleus Software Exports investors has risen faster than earnings growth over the last five years - Simply Wall St | 01/30/2025 |
3 | Nucleus Software Exports Hits 52-Week Low Amid Sustained Downward Trend - MarketsMojo | 02/18/2025 |
Begin Period Cash Flow | 504.9 M | |
Free Cash Flow | 1.9 B |
Nucleus |
Nucleus Software Relative Risk vs. Return Landscape
If you would invest 101,440 in Nucleus Software Exports on December 28, 2024 and sell it today you would lose (20,965) from holding Nucleus Software Exports or give up 20.67% of portfolio value over 90 days. Nucleus Software Exports is generating negative expected returns and assumes 2.6778% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than Nucleus, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Nucleus Software Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nucleus Software's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nucleus Software Exports, and traders can use it to determine the average amount a Nucleus Software's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1283
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NUCLEUS |
Estimated Market Risk
2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
-0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nucleus Software is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nucleus Software by adding Nucleus Software to a well-diversified portfolio.
Nucleus Software Fundamentals Growth
Nucleus Stock prices reflect investors' perceptions of the future prospects and financial health of Nucleus Software, and Nucleus Software fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nucleus Stock performance.
Return On Equity | 0.28 | ||||
Return On Asset | 0.13 | ||||
Profit Margin | 0.18 % | ||||
Operating Margin | 0.14 % | ||||
Current Valuation | 17.98 B | ||||
Shares Outstanding | 26.33 M | ||||
Price To Book | 2.96 X | ||||
Price To Sales | 2.61 X | ||||
Revenue | 8.26 B | ||||
Gross Profit | 2.75 B | ||||
EBITDA | 2.71 B | ||||
Net Income | 1.92 B | ||||
Cash And Equivalents | 159.6 M | ||||
Total Debt | 45.9 M | ||||
Book Value Per Share | 267.64 X | ||||
Cash Flow From Operations | 2.22 B | ||||
Earnings Per Share | 56.33 X | ||||
Total Asset | 11.14 B | ||||
Retained Earnings | 7.29 B | ||||
About Nucleus Software Performance
Assessing Nucleus Software's fundamental ratios provides investors with valuable insights into Nucleus Software's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Nucleus Software is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Nucleus Software is entity of India. It is traded as Stock on NSE exchange.Things to note about Nucleus Software Exports performance evaluation
Checking the ongoing alerts about Nucleus Software for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nucleus Software Exports help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Nucleus Software generated a negative expected return over the last 90 days | |
Nucleus Software is unlikely to experience financial distress in the next 2 years | |
About 76.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Nucleus Software's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nucleus Software's stock is overvalued or undervalued compared to its peers.
- Examining Nucleus Software's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nucleus Software's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nucleus Software's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nucleus Software's stock. These opinions can provide insight into Nucleus Software's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Nucleus Stock Analysis
When running Nucleus Software's price analysis, check to measure Nucleus Software's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nucleus Software is operating at the current time. Most of Nucleus Software's value examination focuses on studying past and present price action to predict the probability of Nucleus Software's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nucleus Software's price. Additionally, you may evaluate how the addition of Nucleus Software to your portfolios can decrease your overall portfolio volatility.